Retatrutide Outperforms Ozempic in Diabetes Trial but Raises Side Effect Concerns | Retatrutide News

Retatrutide surpassed Ozempic in a diabetes trial for blood sugar and weight control but had more dropouts due to side effects. This highlights both its...
Clinical Trials · October 31, 2026